We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.9B
AUM Growth
-$1.68B
Cap. Flow
-$856M
Cap. Flow %
-1.56%
Top 10 Hldgs %
13.5%
Holding
2,578
New
206
Increased
762
Reduced
975
Closed
423

Top Buys

Rank Stock Value
1
DPZ icon
Domino's
DPZ
+$76.7M
2
UNH icon
UnitedHealth
UNH
+$75.4M
3
EQR icon
Equity Residential
EQR
+$65.9M
4
AEP icon
American Electric Power
AEP
+$56.3M
5
EHC icon
Encompass Health
EHC
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.16%
2 Financials 15.86%
3 Technology 13.23%
4 Energy 9.84%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWEN.A
2051
DELISTED
Clearway Energy Class A
CWEN.A
$21K ﹤0.01%
+1,300
New +$22.5K
LILAK icon
2052
Liberty Latin America Class C
LILAK
$1.5B
$21K ﹤0.01%
1,259
-70,209
-98% -$1.29M
AEGN
2053
DELISTED
Aegion Corp
AEGN
$21K ﹤0.01%
900
-1,500
-63% -$36.2K
ISSC icon
2054
Innovative Solutions & Support
ISSC
$342M
$20K ﹤0.01%
5,738
-7,599
-57% -$24.8K
ARA
2055
DELISTED
American Renal Associates Holdings, Inc
ARA
$20K ﹤0.01%
+1,052
New +$20.8K
KEM
2056
DELISTED
KEMET Corporation
KEM
$20K ﹤0.01%
1,110
-13,600
-92% -$249K
VREX icon
2057
Varex Imaging
VREX
$460M
$19K ﹤0.01%
520
-1,120
-68% -$42.7K
HTGM
2058
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$19K ﹤0.01%
+29
New +$21.8K
GNC
2059
DELISTED
GNC Holdings, Inc.
GNC
$19K ﹤0.01%
4,900
-29,300
-86% -$122K
PSDO
2060
DELISTED
Presidio, Inc. Common Stock
PSDO
$19K ﹤0.01%
1,225
-1,075
-47% -$17.9K
JYNT icon
2061
The Joint Corp
JYNT
$119M
$18K ﹤0.01%
2,600
-3,513
-57% -$18.5K
KINS icon
2062
Kingstone Companies
KINS
$288M
$18K ﹤0.01%
1,100
-589
-35% -$11.6K
PLXS icon
2063
Plexus
PLXS
$6.81B
$18K ﹤0.01%
+300
New +$18.4K
LHCG
2064
DELISTED
LHC Group LLC
LHCG
$18K ﹤0.01%
287
-8,300
-97% -$524K
CALA
2065
DELISTED
Calithera Biosciences, Inc
CALA
$18K ﹤0.01%
140
-1,760
-93% -$274K
UCFC
2066
DELISTED
United Community Financial Corp
UCFC
$18K ﹤0.01%
1,794
-18,231
-91% -$176K
VXX
2067
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$18K ﹤0.01%
390
MATX icon
2068
Matsons
MATX
$6.37B
$17K ﹤0.01%
+600
New +$18.8K
MPX
2069
DELISTED
Marine Products Corp
MPX
$17K ﹤0.01%
+1,200
New +$17.1K
PZN
2070
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$17K ﹤0.01%
+1,500
New +$17K
WFT
2071
DELISTED
Weatherford International plc
WFT
$17K ﹤0.01%
7,500
-26,900
-78% -$85.8K
LINC icon
2072
Lincoln Educational Services
LINC
$1.29B
$16K ﹤0.01%
8,200
+600
+8% +$1.11K
SHBI icon
2073
Shore Bancshares
SHBI
$790M
$16K ﹤0.01%
832
-20,193
-96% -$362K
EGRX
2074
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$16K ﹤0.01%
300
-3,100
-91% -$180K
S
2075
DELISTED
Sprint Corporation
S
$16K ﹤0.01%
3,200

Similar funds

Macquarie Group's Q1 2018 Portfolio in Review

As of Q1 2018, Macquarie Group held 2,578 positions worth $54.9B, down 3% from $56.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group's Q1 2018 filing shows 206 new, 762 increased, 975 reduced and 423 closed positions. Its largest new stake was Nutrien: 773,043 shares worth $36.5M. The largest sale was Celgene Corp, an estimated $165M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q1 2018 buy was Nutrien: 773,043 shares worth $36.5M.
  • Macquarie Group added most to Domino's in Q1 2018, an estimated $76.7M increase.
  • Macquarie Group's biggest Q1 2018 reduction was Celgene Corp, cutting an estimated $165M.
  • Macquarie Group fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $50.4M.
  • Macquarie Group's ten largest holdings make up 13% of its $54.9B portfolio in Q1 2018.
  • Macquarie Group opened 206 new positions and closed 423 in Q1 2018.
  • Macquarie Group's portfolio value fell 3% quarter-over-quarter to $54.9B.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.